Longitudinal studies in naïve mice showed that OM-F-MOG remained localized to CD169+ SSM in skin DLN at 14 days post-injection (Figure 6E) and up to the last time point studied (28 days post-injection, not shown). The gene discussed is SIGLEC1; the disease is ocular melanoma.